AstraZeneca Covid-19 Vaccine Effective Against UK Variant in Trial

·

·

AstraZeneca Covid-19 Vaccine Effective Against UK Variant in Trial

LONDON—A Covid-19 vaccine developed by the University of Oxford and AstraZeneca PLC is effective against a variant of coronavirus that is spreading rapidly in the U.S. and around the world, according to a new study, a reassuring sign for governments …
See Original Article

Beazley swings to loss on higher claims activity

Beazley PLC reported Friday a swing to a pretax loss for 2020 driven by a deteriorated combined ratio and said that it is very positive about its performance in 2021. The specialty insurer posted a pretax loss of $50.4 million compared with a profit of $267.7 …
See Original Article

Singapore Billionaire Gets Windfall as Dream Deal Comes True

“The growth will continue,” said Bloomberg Intelligence analyst Horace Chan, who estimates the alliance could lift Nippon Paint's net income by about
See Original Article

Software for Bookkeepers Market Analysis of Global Forecast 2023 By Key Companies – Intuit …

The Global Software for Bookkeepers Market report has been prepared keeping in mind the need of the customers for the latest information in the
See Original Article

Pfizer withdraws application for covid-19 vaccine in India for now

Pfizer had approached the DCGI V.G. Somani for emergency authorisation of its messenger RNA vaccine in December along with Bharat Biotech International and Serum Institute for India, but had so far not made its presentation to the SEC–from whom a crucial …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.